or Try an Advanced Search...

    Technical Analysis for RAPP - Rapport Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 22.55 1.60% 0.36
    RAPP closed down 0.4 percent on Wednesday, November 20, 2024, on 87 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Down
    Historical RAPP trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.60%
    NR7 Range Contraction 1.60%
    Narrow Range Bar Range Contraction 1.60%
    Wide Bands Range Expansion 1.60%
    Oversold Stochastic Weakness 1.60%
    Lower Bollinger Band Walk Weakness 1.19%
    Outside Day Range Expansion 1.19%
    Wide Bands Range Expansion 1.19%
    Lower Bollinger Band Touch Weakness 1.19%
    Oversold Stochastic Weakness 1.19%
    Older End-of-Day Signals for RAPP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 1 hour ago
    Down 1% about 2 hours ago
    Up 1% about 2 hours ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    RAPP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Central Nervous System Disorders

    Is RAPP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting
    Nov 8 Rapport Therapeutics expects cash to fund requirements through 2026
    Nov 7 Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update
    Nov 4 Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November
    Oct 18 This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
    Sep 5 Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
    Aug 29 Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
    Aug 8 Rapport Therapeutics GAAP EPS of -$1.70 misses by $1.02
    Aug 8 Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
    Aug 6 3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns
    See more RAPP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 29.74
    52 Week Low 16.55
    Average Volume 143,055
    200-Day Moving Average 0.00
    50-Day Moving Average 22.72
    20-Day Moving Average 24.19
    10-Day Moving Average 23.53
    Average True Range 1.89
    RSI (14) 45.05
    ADX 17.36
    +DI 18.54
    -DI 29.23
    Chandelier Exit (Long, 3 ATRs) 22.33
    Chandelier Exit (Short, 3 ATRs) 25.87
    Upper Bollinger Bands 28.02
    Lower Bollinger Band 20.36
    Percent B (%b) 0.24
    BandWidth 31.67
    MACD Line -0.41
    MACD Signal Line 0.12
    MACD Histogram -0.5224
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 23.14
    Resistance 3 (R3) 23.17 22.89 22.98
    Resistance 2 (R2) 22.89 22.65 22.87 22.92
    Resistance 1 (R1) 22.54 22.50 22.71 22.51 22.87
    Pivot Point 22.26 22.26 22.34 22.24 22.26
    Support 1 (S1) 21.91 22.02 22.08 21.88 21.51
    Support 2 (S2) 21.63 21.87 21.61 21.46
    Support 3 (S3) 21.28 21.63 21.40
    Support 4 (S4) 21.25